InvestorsHub Logo
Followers 24
Posts 2696
Boards Moderated 0
Alias Born 04/21/2012

Re: None

Tuesday, 12/03/2013 8:58:45 AM

Tuesday, December 03, 2013 8:58:45 AM

Post# of 130505
From Dr. Lowe " orphan indications such as Retinitis Pigmentosa present a tremendous opportunity to speed the time to market for MANF, thereby increasing its net present value at the same time as facilitating success in PD and other indications that have more complicated regulatory pathways."